Search by Drug Name or NDC
NDC 61269-0565-90 ORLISTAT 120 mg/1 Details
ORLISTAT 120 mg/1
ORLISTAT is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by H2-Pharma LLC. The primary component is ORLISTAT.
MedlinePlus Drug Summary
Orlistat (prescription and nonprescription) is used with an individualized low-calorie, low-fat diet and exercise program to help people lose weight. Prescription orlistat is used in overweight people who may also have high blood pressure, diabetes, high cholesterol, or heart disease. Orlistat is also used after weight-loss to help people keep from gaining back that weight. Orlistat is in a class of medications called lipase inhibitors. It works by preventing some of the fat in foods eaten from being absorbed in the intestines. This unabsorbed fat is then removed from the body in the stool.
Related Packages: 61269-0565-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Orlistat
Product Information
NDC | 61269-0565 |
---|---|
Product ID | 61269-565_5b9dc5e8-fe64-4769-bd00-65987c88fa1a |
Associated GPIs | |
GCN Sequence Number | 040663 |
GCN Sequence Number Description | orlistat CAPSULE 120 MG ORAL |
HIC3 | D5A |
HIC3 Description | FAT ABSORPTION DECREASING AGENTS |
GCN | 95213 |
HICL Sequence Number | 018751 |
HICL Sequence Number Description | ORLISTAT |
Brand/Generic | Generic |
Proprietary Name | ORLISTAT |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | orlistat |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 120 |
Active Ingredient Units | mg/1 |
Substance Name | ORLISTAT |
Labeler Name | H2-Pharma LLC |
Pharmaceutical Class | Intestinal Lipase Inhibitor [EPC], Lipase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA AUTHORIZED GENERIC |
Application Number | NDA020766 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61269-0565-90 (61269056590)
NDC Package Code | 61269-565-90 |
---|---|
Billing NDC | 61269056590 |
Package | 90 CAPSULE in 1 BOTTLE, PLASTIC (61269-565-90) |
Marketing Start Date | 2022-06-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 6.98994 |
Pricing Unit | EA |
Effective Date | 2023-12-20 |
NDC Description | ORLISTAT 120 MG CAPSULE |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 6 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis